New Public Webinar Series:
Introduction to Adaptive Trial Designs using FACTS

Live Zoom webinar sessions open to the public on “Introduction to Adaptive Trial Designs using FACTS” will be held this October and November. Each session will cover the design of a different type of trial. Please register in advance if you are interested in attending or receiving a recording. Sign up today at the following links:


  • Phase 1 Dose Escalation, October 5, 2023, 11:00am-12:30pm EST

         Click here to register for this webinar


  • Group Sequential Designs, October 12, 2023, 11:00am-12:30pm EST

         Click here to register for this webinar


  • Phase 2 Arm Dropping and RAR, October 19, 2023, 11:00am-12:30pm EST

         Click here to register for this webinar


  • Seamless Phase 2/3 Trials, October 26, 2023, 11:00am-12:30pm EST

         Click here to register for this webinar


  • Basket Trials, November 2, 2023, 11:00am -12:30pm EST

         Click here to register for this webinar


  • Platform Trials & MAMS designs, November 9, 2023, 11:00am-12:30pm EST

         Click here to register for this webinar  


Checkout Our Latest Videos

View many more videos, webinars, and presentations on our YouTube Channel here.

Other Videos & Webinars

The Implementation of Platform Trials for ALS Research
Dr. Melanie Quintana, statistical scientist and director at Berry Consultants, discussed innovative clinical trial design in ALS research at the 2023 MDA conference.

Adaptive Platform Clinical Trials: Application to ILD
Roger J. Lewis, MD, PhD, lectured on REMAP-ILD at HCOR scientific meeting (Sao Paulo, Brazil).

ANA Highlights Statistical Snapshots Adaptive Designs
Dr. Scott Berry of Berry Consultants presented in the Statistical Snapshots Series: “Adaptive Trial Designs.”

EU-PEARL Webinar – Non-Concurrent Controls in Platform Trials                                                Dr. Scott Berry and Dr. Kert Viele of Berry Consultants presented in the EU-PEARL webinar on February 24. 

Global Coalition for Adaptive Research released a series of Spotlight short videos presented by Don Berry on the GBM AGILE Trial.


PodCast: Bayesian Analysis, Using Prior Information
Roger J. Lewis, MD, PhD, discussed Bayesian Analysis: Using Prior Information to Interpret the Results of Clinical Trials with Melanie Quintana, PhD.

The PRINCIPLE Adaptive Platform Trial for Community Treatment of COVID-19: Innovation in Trial Design and Delivery
Dr. Ben Saville of Berry Consultants and Dr. Chris Butler of Oxford University present a Grand Rounds session on the PRINCIPLE Adaptive Platform Trial.

HEALEY ALS Platform Trial Launch Announcement
Learn more about this groundbreaking trial designed by Berry Consultants to accelerate the development of effective treatments for people in ALS. Weekly updates and additional videos can be found on HEALEY ALS Platform Trial Video Library of Mass General Hospital.

PREPARE (Platform for European Preparedness Against (Re-)emerging Epidemics) releases a series of webinars.


REMAP-CAP (Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia) releases a series of videos:


Introducing Decision-Making Under Uncertainty to Medical Research: Designing More Efficient and More Accurate Clinical Trials
Don Berry’s presentation at the Simons Institute for the Theory of Computing at University of California Berkeley.

The Lowdown on Adaptive Clinical Trials with Don Berry interviews Don Berry through a podcast sponsored by the National Biomarker Development Alliance (NBDA) on July 28, 2014 that discusses a promising new approach to clinical trials.

President’s Council of Advisors on Science and Technology (PCAST)
Don Berry presents as part of a panel of Researchers on the topic of “Improving Scientific Reproducibility in an Age of International Competition and Big Data I” at the PCAST Public Meeting on January 31, 2014.

The Design of Complex Adaptive Trials
Scott Berry presents at the “Transforming Drug Development – Delivering Innovation and Efficiency through Adaptive Clinical Trials” conference that was co-sponsored by Berry Consultants.

A Fully Bayesian World: What a Wonderful World
Scott Berry presents at the Royal Statistical Society’s, “PSI Debate: This house believes that pharmaceutical drug development and regulation should become fully Bayesian”.

Slowly but surely, Bayesian Ideas revolutionize medical research
Don Berry at the 2012 International Society for Bayesian Analysis (ISBA) World Meeting in Kyoto, Japan.

The Biomarkers Consortium: I-SPY 2 Press Conference
Don Berry speaks as part of the press conference for I-SPY 2, an innovative breast cancer clinical trial.